RxDoctor Payments Data

Dan Meirson, MD

MOHS-Micrographic Surgery · Deerfield Beach, FLNPI 1518076330

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Sanofi at 25.5% of the total. 2025 is the largest year on record at $1,188, 6.3 times the $189 reported in 2019.

$3,029in general payments, 2019–2025

Across 120 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$772
  • AbbVie$408
  • Regeneron Healthcare Solutions, Inc.$320
  • Amgen$272
  • LEO Pharma Inc.$204
  • Pfizer$125
  • plus $929 from 17 others

What the payments were for

  • Food & beverage$2,93097%
  • Education$993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,029 in reported general payments places this provider in the 65th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$451,188
Medicare patients
614
Services billed
9,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate147$5,966
Triamcinolone Acetonide296$3,998
Ketoconazole196$3,989
Fluocinonide75$2,550
Metronidazole31$1,572
Ciclopirox62$1,314
Hydrocortisone311$1,255
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip48$923
Clobetasol Propionate25$780
Clindamycin Phosphate41$701
Mupirocin96$601
Doxycycline Hyclate18$283
ValacyclovirValacyclovir Hcl19$233
Sodium ChlorideSodium Chloride Irrig Solution46$226
Cephalexin49$189

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Deerfield Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →